Search

CareDx Inc

Fermé

SecteurSoins de santé

63.37 3.77

Résumé

Variation du prix de l'action

24h

Actuel

Min

63.13

Max

64.91

Chiffres clés

By Trading Economics

Revenu

108M

111M

Ventes

14M

132M

P/E

Moyenne du Secteur

26.12

55.725

BPA

0.17

Marge bénéficiaire

83.848

Employés

761

EBITDA

-3.8M

4.3M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

-15.2% downside

Dividendes

By Acuity

Prochains Résultats

3 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

932M

2.8B

Ouverture précédente

59.6

Clôture précédente

63.37

Sentiment de l'Actualité

By Acuity

46%

54%

96 / 339 Classement par Healthcare

CareDx Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

25 sept. 2026, 20:01 UTC

News
Social Media

CareDx Inc shares are rising amid positive retail commentary and reports of resolved Medicare risk, profitability, and initiated share buybacks, with high trading volume.

24 sept. 2026, 23:05 UTC

CareDx Inc is trading higher in after-market hours, reflecting significant gains since Thursday's close and positioning above its 20-day moving average.

22 sept. 2026, 20:07 UTC

Social Media

CareDx Inc is advancing notably amid options trading commentary and an upgraded price target of $65 from Canaccord Genuity, reflecting strong upward momentum.

16 sept. 2026, 20:10 UTC

CareDx Inc shares are advancing, closing at a notable high and remaining well above their 20-day moving average since Tuesday's close.

15 sept. 2026, 20:07 UTC

CareDx Inc shares are higher today, even as the NY Empire State Manufacturing Index fell sharply, raising concerns about economic contraction in New York's manufacturing sector.

14 sept. 2026, 20:07 UTC

CareDx Inc shares are higher today, continuing a notable gain since Friday's close and reaching a session high earlier. No specific news was identified.

12 sept. 2026, 00:01 UTC

CareDx Inc shares are higher in after-market hours, with no specific news driving the move. The broader market reflects inflation data and interest rate speculation.

11 sept. 2026, 20:08 UTC

CareDx Inc. shares are higher today, reflecting a broader market trend. The stock remains above its 20-day moving average, indicating relative strength.

8 sept. 2026, 20:07 UTC

CareDx Inc shares are declining today amid broader market trends. The stock reached a session low earlier, remaining lower since Friday's close.

2 sept. 2026, 20:08 UTC

News

Canaccord Genuity initiated coverage on CareDx with a Buy rating and a $65 price target, contributing to the stock's upward movement during the session.

1 sept. 2026, 20:09 UTC

CareDx Inc shares are lower amid a broader market downturn. Investors are responding to macroeconomic concerns, including rising oil prices and inflation worries.

31 août 2026, 20:07 UTC

CareDx Inc shares are higher, recovering from an early dip amid broader market volatility and macroeconomic concerns regarding inflation and interest rates.

28 août 2026, 23:56 UTC

CareDx Inc shares are higher in after-market hours, reflecting a generally strong performance backdrop amid rising market expectations for a potential interest rate hike.

27 août 2026, 19:51 UTC

Shares of CareDx Inc. are advancing amid unusually high trading volume. Earlier in the session, shares pulled back from a session high.

26 août 2026, 20:08 UTC

CareDx Inc shares are higher today, regaining momentum after earlier pulling back. The broader market reflects mixed performance amid recent inflation data.

25 août 2026, 20:07 UTC

CareDx Inc. shares are higher today, reflecting a strong upward move since Monday amid easing Treasury yields that support equities and investor sentiment.

24 août 2026, 19:26 UTC

Social Media

CareDx Inc shares are lower today, despite social media discussions projecting a price target of $75 by 2027 and expected revenues of $575 million.

21 août 2026, 23:01 UTC

CareDx Inc shares are higher in after-market trading, reflecting notable activity despite broader market volatility and no specific company news identified.

20 août 2026, 20:06 UTC

CareDx Inc. shares are higher, recovering from an earlier pullback, amid rising crude oil prices and increased U.S. Treasury yields influencing market dynamics.

19 août 2026, 23:56 UTC

CareDx Inc shares are higher in after-market hours, remaining above their 20-day moving average. No specific news was identified to explain the movement.

18 août 2026, 20:04 UTC

CareDx Inc shares are lower today, reflecting broader market trends amid rising U.S. Treasury yields and inflation concerns. The stock remains down since Monday's close.

14 août 2026, 20:02 UTC

CareDx Inc shares are lower today amid notable volatility. A recent report showed an unexpected drop in U.S. retail sales, impacting broader market sentiment.

12 août 2026, 19:36 UTC

CareDx Inc. shares are lower today, reflecting a slight decline since Tuesday's close, despite earlier rebounding from a session low.

11 août 2026, 23:41 UTC

CareDx Inc shares advanced in after-market trading, reflecting notable gains since Tuesday's close. The stock remains well above its 20-day moving average.

10 août 2026, 23:46 UTC

CareDx Inc shares are higher in after-market hours, trading significantly above their 20-day moving average and near the upper end of their one-month range.

7 août 2026, 20:06 UTC

CareDx Inc shares are higher today, recovering from an early dip. The stock has gained significantly since Thursday amid a decline in Treasury yields.

5 août 2026, 19:46 UTC

Shares of CareDx Inc. are lower today amid unusual volatility, reflecting a broader market sentiment influenced by disappointing employment data from ADP.

4 août 2026, 21:36 UTC

CareDx Inc shares are higher in after-market trading, reflecting a broader U.S. stock rally amid declining crude oil prices easing inflation concerns.

3 août 2026, 20:02 UTC

News

CareDx Inc shares rise following a rating upgrade to Buy from Craig-Hallum and a new price target of $64, up from $35.

31 juil. 2026, 23:06 UTC

News

CareDx shares are lower in after-market hours despite a 52% revenue increase to $132 million and raised full-year guidance to $490 million-$500 million.

Comparaison

Variation de prix

CareDx Inc prévision

Objectif de Prix

By TipRanks

-15.2% baisse

Prévisions sur 12 Mois

Moyen 54 USD  -15.2%

Haut 74 USD

Bas 21 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

6 ratings

3

Achat

3

Maintien

0

Vente

Sentiment

By Acuity

96 / 339Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.